Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)Tara C. Mitchell, Thomas F. Gajewski|Journal of Clinical Oncology|2018Cited by 382
Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigeneticsJosephine R. Giles, E. John Wherry, Shin Foong Ngiow et al.|Nature Immunology|2022Cited by 255
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancersJosephine R. Giles, E. John Wherry, Sasikanth Manne et al.|Immunity|2022Cited by 122
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast CarcinomaPayal D. Shah, Tara C. Mitchell|Cancer Research Communications|2023Cited by 90
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal CancerThomas B. Karasic, Peter J. O’Dwyer, Ravi K. Amaravadi et al.|The Oncologist|2022Cited by 33